Unknown

Dataset Information

0

Structure-activity relationship of pyrrolyl diketo acid derivatives as dual inhibitors of HIV-1 integrase and reverse transcriptase ribonuclease H domain.


ABSTRACT: The development of HIV-1 dual inhibitors is a highly innovative approach aimed at reducing drug toxic side effects as well as therapeutic costs. HIV-1 integrase (IN) and reverse transcriptase-associated ribonuclease H (RNase H) are both selective targets for HIV-1 chemotherapy, and the identification of dual IN/RNase H inhibitors is an attractive strategy for new drug development. We newly synthesized pyrrolyl derivatives that exhibited good potency against IN and a moderate inhibition of the RNase H function of RT, confirming the possibility of developing dual HIV-1 IN/RNase H inhibitors and obtaining new information for the further development of more effective dual HIV-1 inhibitors.

SUBMITTER: Cuzzucoli Crucitti G 

PROVIDER: S-EPMC7745740 | biostudies-literature | 2015 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications


The development of HIV-1 dual inhibitors is a highly innovative approach aimed at reducing drug toxic side effects as well as therapeutic costs. HIV-1 integrase (IN) and reverse transcriptase-associated ribonuclease H (RNase H) are both selective targets for HIV-1 chemotherapy, and the identification of dual IN/RNase H inhibitors is an attractive strategy for new drug development. We newly synthesized pyrrolyl derivatives that exhibited good potency against IN and a moderate inhibition of the RN  ...[more]

Similar Datasets

| S-EPMC7236236 | biostudies-literature
| S-EPMC8279492 | biostudies-literature
| S-EPMC4203401 | biostudies-literature
| S-EPMC8320704 | biostudies-literature
| S-EPMC5357622 | biostudies-literature
| S-EPMC8457747 | biostudies-literature
| S-EPMC4509971 | biostudies-literature
| S-EPMC3070847 | biostudies-literature
| S-EPMC1161920 | biostudies-other
| EMPIAR-10642 | biostudies-other